Postoperative complications in the treatment of rectal neoplasia by transanal endoscopic microsurgery: a prospective study of risk factors and time course

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, v.31, n.4, p.833-841, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Transanal endoscopic microsurgery (TEM) is a safe and efficient minimally invasive treatment for rectal benign and early malignant neoplasia, but postoperative complications may be severe. We aimed to evaluate the risk factors related to the incidence, severity, and time course of postoperative complications of TEM. This is a prospective study of postoperative complications in 53 patients (> 18 years old) with benign or early rectal neoplasia who underwent TEM with curative intention or, for higher stages, palliation. Outcome measures included age, sex, American Society of Anesthesiologists score, neoadjuvant chemoradiotherapy, lesion height and size, pathologic margins, tumor histology, and suture type. Overall morbidity was 50 %. Temporary fecal incontinence was the most frequent complication (17.3 %). Complication rates of Clavien-Dindo grades I and II were 21.1 % and those of grades III and IV 3.8 %. Of patients with complications, more had lesions under the first rectal valve than over the first valve (61.54 % vs 38.46 %, p = 0.04). Patients submitted to chemoradiotherapy had a 24-fold greater chance of presenting grade II complications (p = 0.002). When the surgical defect was treated using the TEM device to perform the suture, the chance of having grade III complications was reduced 16-fold (p = 0.04). Fifty-three percent of complications occurred in the first 10 days and 95 % within 20 days. Postoperative complications after transanal endoscopic microsurgery for the treatment of rectal neoplasia are frequent, acceptable, and usually controllable with pharmacologic treatment. Over time the nature of complications is continuous, centered on the first 20 days after surgery.
Palavras-chave
Organ-sparing treatment, Minimally invasive surgery, Transanal endoscopicmicrosurgery, Postoperative complications, Risk factors
Referências
  1. Barendse RM, 2011, ENDOSCOPY, V43, P941, DOI 10.1055/s-0030-1256765
  2. Mentges B, 1996, CHIRURG, V67, P133
  3. Langer C, 2001, SURG ENDOSC-ULTRAS, V15, P513, DOI 10.1007/s004640090015
  4. Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4
  5. De Graaf EJR, 2009, EJSO-EUR J SURG ONC, V35, P1280, DOI 10.1016/j.ejso.2009.05.001
  6. de Graaf EJR, 2011, COLORECTAL DIS, V13, P762, DOI 10.1111/j.1463-1318.2010.02269.x
  7. Allaix ME, 2009, DIS COLON RECTUM, V52, P1831, DOI 10.1007/DCR.0b013e3181b14d2d
  8. Garcia-Aguilar J, 2010, SURG ONCOL CLIN N AM, V19, P743, DOI 10.1016/j.soc.2010.08.002
  9. Morino M, 2013, TECH COLOPROCTOL, V17, pS55, DOI 10.1007/s10151-012-0936-0
  10. Tytherleigh MG, 2008, BRIT J SURG, V95, P409, DOI 10.1002/bjs.6127
  11. Allaix ME, 2013, ANN SURG ONCOL, V20, P2921, DOI 10.1245/s10434-013-2966-x
  12. Dias AR, 2009, TECH COLOPROCTOL, V13, P105, DOI 10.1007/s10151-009-0466-6
  13. Gracia JA, 2011, SURG ENDOSC, V25, P3209, DOI 10.1007/s00464-011-1695-0
  14. Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2
  15. Lezoche G, 2008, SURG ENDOSC, V22, P352, DOI 10.1007/s00464-007-9596-y
  16. Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694
  17. Winde G, 1997, MINIM INVASIV THER, V6, P315, DOI 10.3109/13645709709153083
  18. BUESS G, 1988, GASTROENTEROLOGY, V94, pA53
  19. Lange MM, 2009, EJSO-EUR J SURG ONC, V35, P456, DOI 10.1016/j.ejso.2008.09.012